Drug development in the AI era:AlphaFold 3 is coming!

作     者：Yi Shi 

作者机构：CAS Key Laboratory of Pathogen Microbiology and ImmunologyInstitute of MicrobiologyChinese Academy of Sciences(CAS)Beijing 100101China Medical SchoolUniversity of Chinese Academy of SciencesBeijing 100049China Beijing Life Science AcademyBeijing 102209China Health Science CenterNingbo UniversityNingbo 315211China 

出 版 物：《The Innovation》 (创新（英文）)

年 卷 期：2024年第5卷第5期

页      面：25-26页

核心收录：

学科分类：0202[经济学-应用经济学] 02[经济学] 020205[经济学-产业经济学] 

基　　金：supported by the National Key Research and Development Program of China(2021YFC2300200 and 2021YFC2300700) the National Natural Science Foundation of China(NSFC)(32192452 and 82241076) 

主　　题：approval Figure dollar 

摘      要：For decades,researchers have sought a convenient,reliable,and fast track to drug ***,it takes about 12–15 years from the initial drug discovery stage to the point at which the drug gets approval by national drug administration ***,when we consider the costs of both successful and failed programs,it costs about 2.5 billion US dollars to bring a drug to market(Figure 1).How to reduce the time and costs required for drug development is a subject that we are always thinking deeply about.